-
Symbol
-
ABUS on Nasdaq
-
Investment type
-
Equity / Common Shares, without par value
-
Latest Disclosed Ownership
-
38.8M shares
-
Security Ownership
-
20.5%
Roivant Sciences Ltd. ownership in Arbutus Biopharma Corp Common Shares, without par value (ABUS)
2025-02-25 - Roivant Sciences Ltd. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 38.8M shares of Arbutus Biopharma Corp Common Shares, without par value (ABUS).
This represents 20.5% percent ownership of the company.